Acetylcholinesterase inhibitors coated Nano-particles conjugates
Tech ID
P26-1029
Patent Status
Granted
Design Status
--
Technical Description
Alzheimer’s disease (AD) is a neurodegenerative disease that slowly destroys memory and thinking skills, and eventually affects even the ability to carry out the simplest tasks.
The present invention relates to Acetylcholinesterase (Ache) inhibitors coated nanoparticle conjugates for the treatment of neurodegenerative disorders such as Alzheimer’s disease.
TARGET AUDIENCE
- Healthcare facilities, Hospitals
- Alzheimer’s disease patient centred care
- Pharma Industry
- Research & Development Sector
TECH FEATURES
- Low dose administration
- Enhanced bioavailability
- Longer Stability
- Longer half-life
- Minimal side effects
P26-1029
Send download link to email.
Available For
Exclusive and Non Exclusive License Sell off in respective territory
Cost
On Request
Stage of Developments
Technology is ready and validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com